These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35505495)

  • 21. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang TF; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R; Feng M; Simpson P; Billett HH
    Thromb Res; 2021 Jun; 202():155-161. PubMed ID: 33862470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy.
    Livneh N; Braeken D; Drozdinsky G; Gafter-Gvili A; Seelig J; Rozovski U; Berger T; Raanani P; Falanga A; Ten Cate H; Spectre G; Leader A
    J Thromb Thrombolysis; 2021 Aug; 52(2):590-596. PubMed ID: 33523384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.
    Napolitano M; Saccullo G; Marietta M; Carpenedo M; Castaman G; Cerchiara E; Chistolini A; Contino L; De Stefano V; Falanga A; Federici AB; Rossi E; Santoro R; Siragusa S; ; ; De Stefano V; Falanga A; Tosetto A; Avvisati G; Carpenedo M; Federici AB; Marietta M; Napolitano M; Rossi E; Santoro C; Castaman G; Cerchiara E; Chistolini A; Contino L; Mazzucconi MG; Nichele I; Russo L; Santi R; Santoro RC; Siragusa S; Tagariello G
    Blood Transfus; 2019 May; 17(3):171-180. PubMed ID: 30418130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature.
    Annibali O; Napolitano M; Avvisati G; Siragusa S
    Crit Rev Oncol Hematol; 2018 Apr; 124():41-50. PubMed ID: 29548485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of cancer-associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement.
    Held N; Jung B; Baumann Kreuziger L
    Res Pract Thromb Haemost; 2022 May; 6(4):e12726. PubMed ID: 35664532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
    Al-Samkari H; Connors JM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):71-79. PubMed ID: 31808892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and outcomes of single subsegmental pulmonary embolus: a retrospective audit at North Shore Hospital, New Zealand.
    Mehta D; Barnett M; Zhou L; Woulfe T; Rolfe-Vyson V; Rowland V; Simpson D; Merriman E
    Intern Med J; 2014 Sep; 44(9):872-6. PubMed ID: 24942202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation.
    Martens KL; Amos CI; Hernandez CR; Kebriaei P; da Costa WL; Basom R; Davis C; Kesten M; Carrier M; Garcia DA; Lee SJ; Li A
    Am J Hematol; 2021 Sep; 96(9):1137-1146. PubMed ID: 34097772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
    Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
    Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
    Kopolovic I; Lee AY; Wu C
    Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.
    Estcourt LJ; Malouf R; Hopewell S; Doree C; Van Veen J
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011980. PubMed ID: 29709077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients.
    Yamashita Y; Unoki T; Takagi D; Hamatani Y; Ishii M; Iguchi M; Ogawa H; Masunaga N; Wada H; Hasegawa K; Abe M; Akao M
    Heart Vessels; 2016 Jul; 31(7):1084-90. PubMed ID: 26135928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after inferior vena cava filter placement in cancer patients diagnosed with pulmonary embolism: risk for recurrent venous thromboembolism.
    Coombs C; Kuk D; Devlin S; Siegelbaum RH; Durack JC; Parameswaran R; Mantha S; Deng K; Soff G
    J Thromb Thrombolysis; 2017 Nov; 44(4):489-493. PubMed ID: 28993967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Challenges in the Management of Acute Pulmonary Embolism in a Cancer Patient with Chemotherapy-induced Thrombocytopenia.
    Sreh A; Nakeshree S; Krishnasamy SK; Alfasi N
    Eur J Case Rep Intern Med; 2018; 5(1):000713. PubMed ID: 30755972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Presentation, Treatment, and Outcomes of Venous Thromboembolism in Long-Term Immobile Patients Based on Age.
    Weinberg I; Elgendy IY; Dicks AB; Marchena PJ; Malý R; Francisco I; Pedrajas JM; Font C; Hernández-Blasco L; Monreal M;
    J Gen Intern Med; 2023 Jun; 38(8):1877-1886. PubMed ID: 36750505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.